Filing Details

Accession Number:
0000899243-17-018597
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-19 20:54:05
Reporting Period:
2017-07-17
Filing Date:
2017-07-19
Accepted Time:
2017-07-19 20:54:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596946 Quotient Ltd QTNT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226486 E Paul J D Cowan 28 Esplanade
St. Helier Y9 JE2 3QA
See Remarks Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2017-07-17 45,032 $6.57 3,513,477 No 4 S Indirect By spouse
Ordinary Shares Disposition 2017-07-18 20,580 $6.29 3,492,897 No 4 S Indirect By spouse
Ordinary Shares Disposition 2017-07-19 24,968 $6.14 3,467,929 No 4 S Indirect By spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By spouse
No 4 S Indirect By spouse
No 4 S Indirect By spouse
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 26,666 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Ordinary Shares Employee Stock Option (right to buy) $11.92 2026-05-31 35,000 35,000 Direct
Ordinary Shares Multi-year Performance Based Restricted Stock Units $0.00 2018-12-31 42,000 42,000 Direct
Ordinary Shares Multi-year Performance Based Restricted Stock Units $0.00 2018-12-31 42,000 42,000 Direct
Ordinary Shares Employee Stock Option (right to buy) $15.17 2025-05-19 35,000 35,000 Direct
Ordinary Shares Option to purchase ordinary shares $3.29 2024-06-27 123,431 123,431 Direct
Ordinary Shares Employee Stock Option (right to buy) $8.00 2024-04-29 90,000 90,000 Direct
Ordinary Shares Employee Stock Option (right to buy) $7.58 2027-05-23 50,000 50,000 Direct
Ordinary Shares Multi-year Performance Based Restricted Stock Unit $0.00 2019-12-31 60,000 60,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2026-05-31 35,000 35,000 Direct
2018-12-31 42,000 42,000 Direct
2018-12-31 42,000 42,000 Direct
2025-05-19 35,000 35,000 Direct
2024-06-27 123,431 123,431 Direct
2024-04-29 90,000 90,000 Direct
2027-05-23 50,000 50,000 Direct
2019-12-31 60,000 60,000 Direct
Footnotes
  1. Sold by Quotient Biodiagnostics Group Limited pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.31 to $6.90, inclusive. The Reporting Person undertakes to provide Quotient, any security holder of Quotient, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. Deidre Cowan, Mr. Cowan's spouse, exercises sole voting and dispositive power over the shares.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.175 to $6.51, inclusive. The Reporting Person undertakes to provide Quotient, any security holder of Quotient, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.93 to $6.27, inclusive. The Reporting Person undertakes to provide Quotient, any security holder of Quotient, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  6. 11,667 options vested on June 1, 2017 and remain exercisable, 11,667 options will vest on June 1, 2018, 11,666 options will vest on June 1, 2019.
  7. Each Multi-year Performance Based Restricted Stock Unit ("MRSU") represents a contingent right to receive one share of Quotient's ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $40.00 per share for 20 consecutive trading days during the period April 1, 2018 to December 31, 2018.
  8. Each MRSU represents a contingent right to receive one share of Quotient ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $60.00 per share for 20 consecutive trading days during the period April 1, 2018 to December 31, 2018.
  9. 23,334 options have vested and remain exercisable, 11,666 options will vest on May 20, 2018.
  10. All 123,431 options have vested and remain exercisable.
  11. All 90,000 options have vested and remain exercisable.
  12. The options will vest and become exercisable in three equal annual installments beginning on May 24, 2018.
  13. Each MRSU represents a contingent right to receive one share of Quotient's ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $22.00 per share for 20 consecutive trading days during the period April 1, 2019 to December 31, 2019.